TransAlgae Israel Ltd
|Company:||TransAlgae Israel Ltd|
|Name:||Dr Doron Eisenstadt|
|Designation:||VP Product Development|
|Mobile:||+972 54 2218169|
|Fax:||+972 8 9366165|
|Technology Classification:||Protein Oral Delivery - Algae|
|Main Business Activity:||Algae Production for Protein Oral Delivery|
Company Profile, Products & Technologies, Target Market:
Founded in 2008, TransAlgae is a biotech company incorporated in the USA, with a research center located at the Weizmann Science Park in Rehovot, Israel. TransAlgae develops and cultivates a variety of enhanced algae possessing high value products for the global aquaculture and animal husbandry markets.
Brief description of proposed R&D project:
To develop a technology platform that harnesses algae as cell factories for the production of customized or off-the-shelf bio-molecules. These products, will be comprised of dried modified algae that will contain enzymes, active molecules, vaccines or other proteins, which will be engineered for oral delivery as food supplements.
Role of Requesting Company in Proposed R&D Project:
TransAlgae has successfully transformed different species of algae with various functional proteins. Enhanced algae enable oral delivery of many proteins thereby avoiding the use of current inferior techniques, such as injections. TransAlgae has a proven ability to orally deliver selected proteins to shrimp and fish, and intends to attempt the oral delivery of proteins such as vaccines to other species of the animal husbandry industry.
Desired Profile of R&D Partner and its role in the proposed project:
Fish feed producing company that will co-develop pipeline products and conduct feeding trials.